These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4338719)

  • 1. [Presence of C-particle group-specific antigens in the liquid phase of mouse ascitic tumors].
    Ribacchi R
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1971; 31(3):91-102. PubMed ID: 4338719
    [No Abstract]   [Full Text] [Related]  

  • 2. [The course of mammary carcinoma. New immunopathologic parameters of evaluation. Experimental study in mice (MuMT). IV. Correlation of blood picture, splenogram and ascitic fluid cells].
    Behmer OA; Zanotto A; de Tolosa EM; Gomes DM
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(2):44-8. PubMed ID: 3441726
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunology of mammary cancer in mice].
    Hollmann KH
    Rev Eur Etud Clin Biol; 1971 Dec; 16(10):969-80. PubMed ID: 4110762
    [No Abstract]   [Full Text] [Related]  

  • 4. Relation between the tumor-specific antigen and cytological characteristics in mouse mammary tumors.
    Irie RF; Koyama K; Hino S
    J Natl Cancer Inst; 1970 Sep; 45(3):515-24. PubMed ID: 5523194
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary report. Antigenicity of the mice Ehrlich ascitic tumor cell nuclei.
    Zitnan D; Cebecauer L; Ujházy V
    Neoplasma; 1969 Jun; 16(3):339-41. PubMed ID: 4981697
    [No Abstract]   [Full Text] [Related]  

  • 6. Search for cross-reacting antigenicity between mammary tumor virus-induced mammary tumors and embryonic antigens: effect of immunization on development of spontaneous mammary tumors.
    Blair PB
    Cancer Res; 1970 Apr; 30(4):1199-202. PubMed ID: 4323352
    [No Abstract]   [Full Text] [Related]  

  • 7. Transplantability and antigenicity of two sublines of the TA3 tumor.
    Sanford BH; Codington JF; Jeanloz RW; Palmer PD
    J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of parabiosis on tumour growth in tumour bearing animals.
    Postuma HS
    Arch Chir Neerl; 1973; 25(3):269-82. PubMed ID: 4355262
    [No Abstract]   [Full Text] [Related]  

  • 9. Progressive growth of transplanted tumors is accompanied by increasing serum concentrations of murine gamma fetal antigen.
    Higgins PJ; Marucs S; Hawrylko E
    Oncodev Biol Med; 1981; 2(1-2):77-87. PubMed ID: 6795603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tube leukocyte adherence-inhibition response to related and unrelated tumor antigens in mammary tumor-bearing mice.
    Chattopadhyay U; Guha S
    Tumori; 1983 Aug; 69(4):299-303. PubMed ID: 6623652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen specificity and immunogenic capacity of 3m KCl cell extracts from ascites tumour ATPCplus.
    Marconi P; Bistoni F; Pitzurra M
    Boll Ist Sieroter Milan; 1974; 53(2):377-91. PubMed ID: 4214542
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitation of mouse mammary tumor virus (MTV) virions by radioimmunoassay.
    Cardiff RD
    J Immunol; 1973 Dec; 111(6):1722-9. PubMed ID: 4356324
    [No Abstract]   [Full Text] [Related]  

  • 13. [Gel filtration and immunoelectrophoresis of serum proteins in tumors and in tissue regressive processes].
    Brucchieri A; Billitteri A
    Sperimentale; 1969; 119(6):447-53. PubMed ID: 5406738
    [No Abstract]   [Full Text] [Related]  

  • 14. [Detection of the antigenic properties of Ehrlich mouse carcinoma cells following their treatment with lonin-3 preparation].
    Montsevichiute-Bringene
    Biull Eksp Biol Med; 1965 Nov; 60(11):68-71. PubMed ID: 4960837
    [No Abstract]   [Full Text] [Related]  

  • 15. Tissue culture studies of mouse mammary tumor cells and associated viruses.
    Owens RB; Hackett AJ
    J Natl Cancer Inst; 1972 Nov; 49(5):1321-32. PubMed ID: 4346536
    [No Abstract]   [Full Text] [Related]  

  • 16. [Course of mammary carcinoma. New immunopathological parameters of evaluation. Experimental study in mice (MuMT). III--Ascitic fluid].
    Behmer OA; Zanotto A; Castro de Tolosa EM; do Nascimento JJ; da Silva RG
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(1):4-7. PubMed ID: 3423602
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunity to the T1699 murine mammary tumor. II. Thymic influence on the in situ inflammatory response, metastatic growth and invasiveness.
    Parthenais E; Haskill S
    J Immunol; 1979 Sep; 123(3):1334-8. PubMed ID: 313951
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody formation for malignant tumor. 3. Antigenicity of peptide of ribosomal digest in Ehrlich ascites tumor.
    Yamamoto Y; Jituiki D; Yabuki Y
    Acta Med Okayama (1952); 1970 Oct; 24(5):534-7. PubMed ID: 4256472
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anticomplement activity of the serum, ascitic fluid and tumor fluid of animals with transplantable experimental neoplasms. Cytotoxic activity of the antibodies].
    Valguarnera G
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):1013-6. PubMed ID: 4463978
    [No Abstract]   [Full Text] [Related]  

  • 20. Surface antigen on Ehrlich ascites tumor cells.
    Pessina A; Brambilla P; Mocarelli P
    Biomedicine; 1980; 33(4):105-9. PubMed ID: 7000194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.